Organisation paid for research Program year 2025 Source: CMS Open Payments

Elligo Hlth Rsrch

Neither a doctor nor a teaching hospital

Research payments

$2,150,771

408 payments

Through program year 2025, Elligo Hlth Rsrch is reported as receiving $2,150,771 in research payments, across 408 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$397,028	103
2024	Research	$694,952	140
2023	Research	$1,019,127	161
2022	Research	$39,664	4

Breakdown

Who paid Research payments · program years 2022–2025

Janssen Research & Development, LLC $2,009,127 399 payments
Janssen Pharmaceuticals, Inc $141,644 9 payments

Studies the money was for Research payments · program years 2022–2025

A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years $697,502 210 payments
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Aticaprant 10 mg and 5 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate to Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. $673,616 83 payments
67953964Mdd3003 $376,401 57 payments
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) $158,836 25 payments
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older $141,644 9 payments
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT) $71,875 20 payments
80202135Cdp3001 $30,897 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.